Overall in-hospital mortality
LIMA patency
Injury at the re-entry
LIMA injury
|
7.8% (14/178)
7.8% (10/127)
23.8% (5/21)
16.6% (2/12)
|
5.5% (5/90)
4.3% (3/69)
0
0
|
10.2% (9/88)
12.0% (7/58)
29.4% (5/17)
20.0% (2/10)
|
0.247
0.201
0.555
0.729
|
Group 1 – re-sternotomy for isolated aortic valve replacement
with patent coronary grafts
Group 2 – re-sternotomy for aortic valve replacement +/- other
concomitant cardiac procedure with patent coronary grafts
LIMA – Left Internal Mammary Artery, LOS – Length of Stay
* Composite of in-hospital mortality, postoperative TIA/stroke,
renal failure requiring new hemofiltration, deep sternal wound
infection, re-exploration for bleeding/tamponade and length of stay
>30 days
|
Group 1 – re-sternotomy for isolated aortic valve replacement
with patent coronary grafts
Group 2 – re-sternotomy for aortic valve replacement +/- other
concomitant cardiac procedure with patent coronary grafts
LIMA – Left Internal Mammary Artery, LOS – Length of Stay
* Composite of in-hospital mortality, postoperative TIA/stroke,
renal failure requiring new hemofiltration, deep sternal wound
infection, re-exploration for bleeding/tamponade and length of stay
>30 days
|
Group 1 – re-sternotomy for isolated aortic valve replacement
with patent coronary grafts
Group 2 – re-sternotomy for aortic valve replacement +/- other
concomitant cardiac procedure with patent coronary grafts
LIMA – Left Internal Mammary Artery, LOS – Length of Stay
* Composite of in-hospital mortality, postoperative TIA/stroke,
renal failure requiring new hemofiltration, deep sternal wound
infection, re-exploration for bleeding/tamponade and length of stay
>30 days
|
Group 1 – re-sternotomy for isolated aortic valve replacement
with patent coronary grafts
Group 2 – re-sternotomy for aortic valve replacement +/- other
concomitant cardiac procedure with patent coronary grafts
LIMA – Left Internal Mammary Artery, LOS – Length of Stay
* Composite of in-hospital mortality, postoperative TIA/stroke,
renal failure requiring new hemofiltration, deep sternal wound
infection, re-exploration for bleeding/tamponade and length of stay
>30 days
|
Group 1 – re-sternotomy for isolated aortic valve replacement
with patent coronary grafts
Group 2 – re-sternotomy for aortic valve replacement +/- other
concomitant cardiac procedure with patent coronary grafts
LIMA – Left Internal Mammary Artery, LOS – Length of Stay
* Composite of in-hospital mortality, postoperative TIA/stroke,
renal failure requiring new hemofiltration, deep sternal wound
infection, re-exploration for bleeding/tamponade and length of stay
>30 days
|